Specifically, they identified LOF variants governing TLR3- and IRF7-dependent type I IFN production in 3.5% of a group of 659 hospitalized COVID-19 patients, with a significant enrichment in these variants in individuals with life-threatening pneumonia compared to a control group with asymptomatic or benign infection. This evidence concerns the gene TLR3 and infection.